20-13788577-C-CT

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PVS1_ModerateBP6

The NM_024120.5(NDUFAF5):​c.264-3dupT variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000352 in 1,570,674 control chromosomes in the GnomAD database, including 1 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00037 ( 1 hom. )

Consequence

NDUFAF5
NM_024120.5 splice_acceptor, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: -1.85

Publications

0 publications found
Variant links:
Genes affected
NDUFAF5 (HGNC:15899): (NADH:ubiquinone oxidoreductase complex assembly factor 5) The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes a mitochondrial protein that is associated with the matrix face of the mitochondrial inner membrane and is required for complex I assembly. A mutation in this gene results in mitochondrial complex I deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
NDUFAF5 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial complex I deficiency, nuclear type 16
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial complex I deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.061657034 fraction of the gene. Cryptic splice site detected, with MaxEntScore 11, offset of 0 (no position change), new splice context is: tctgtgtcttttttttttAGaaa. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 20-13788577-C-CT is Benign according to our data. Variant chr20-13788577-C-CT is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377336.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024120.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NDUFAF5
NM_024120.5
MANE Select
c.264-3dupT
splice_acceptor intron
N/ANP_077025.2
NDUFAF5
NM_001039375.3
c.264-3dupT
splice_acceptor intron
N/ANP_001034464.1
NDUFAF5
NM_001352408.2
c.264-3dupT
splice_acceptor intron
N/ANP_001339337.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NDUFAF5
ENST00000378106.10
TSL:1 MANE Select
c.264-12_264-11insT
intron
N/AENSP00000367346.5
NDUFAF5
ENST00000463598.1
TSL:1
c.264-12_264-11insT
intron
N/AENSP00000420497.1
NDUFAF5
ENST00000378081.9
TSL:2
n.264-12_264-11insT
intron
N/AENSP00000437325.1

Frequencies

GnomAD3 genomes
AF:
0.000179
AC:
27
AN:
150928
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000330
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.000484
GnomAD2 exomes
AF:
0.000150
AC:
36
AN:
239352
AF XY:
0.000147
show subpopulations
Gnomad AFR exome
AF:
0.000318
Gnomad AMR exome
AF:
0.0000302
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000227
Gnomad FIN exome
AF:
0.0000483
Gnomad NFE exome
AF:
0.000186
Gnomad OTH exome
AF:
0.000172
GnomAD4 exome
AF:
0.000371
AC:
526
AN:
1419634
Hom.:
1
Cov.:
28
AF XY:
0.000346
AC XY:
245
AN XY:
707886
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000583
AC:
19
AN:
32618
American (AMR)
AF:
0.0000451
AC:
2
AN:
44322
Ashkenazi Jewish (ASJ)
AF:
0.000195
AC:
5
AN:
25586
East Asian (EAS)
AF:
0.000257
AC:
10
AN:
38978
South Asian (SAS)
AF:
0.000200
AC:
17
AN:
84982
European-Finnish (FIN)
AF:
0.0000570
AC:
3
AN:
52624
Middle Eastern (MID)
AF:
0.000530
AC:
3
AN:
5664
European-Non Finnish (NFE)
AF:
0.000412
AC:
443
AN:
1076074
Other (OTH)
AF:
0.000408
AC:
24
AN:
58786
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.304
Heterozygous variant carriers
0
61
122
182
243
304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000179
AC:
27
AN:
151040
Hom.:
0
Cov.:
33
AF XY:
0.000230
AC XY:
17
AN XY:
73782
show subpopulations
African (AFR)
AF:
0.000291
AC:
12
AN:
41172
American (AMR)
AF:
0.000330
AC:
5
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4764
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000133
AC:
9
AN:
67692
Other (OTH)
AF:
0.000479
AC:
1
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000304
Hom.:
0
Bravo
AF:
0.000212
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Nov 07, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Oct 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 08, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Feb 05, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: NDUFAF5 c.264-3dupT alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. To our knowledge, no occurrence of c.264-3dupT in individuals affected with Leigh Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 377336). Based on the evidence outlined above, the variant was classified as uncertain significance.

Inborn genetic diseases Benign:1
Jun 09, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751750631; hg19: chr20-13769223; COSMIC: COSV52521307; COSMIC: COSV52521307; API